Electrooxidation of sulfanilamide and its voltammetric determination in pharmaceutical formulation,

来源 :药物分析学报(英文) | 被引量 : 0次 | 上传用户:sgaini1532
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
For the first time, sulfanilamide (SFD) was determined in otologic solution, human urine and serum by electroanalytical techniques on glassy carbon electrode (GCE). The cyclic voltammetry (CV) experiments showed an irreversible oxidation peak at +1.06 V in 0.1 mol/L BRBS (pH = 2.0) at 50 mV/s. Different vol-tammetric scan rates (from 10 to 250 mV/s) suggested that the oxidation of SFD on the GCE was a diffusion-controlled process. Square-wave voltammetry (SWV) method under optimized conditions showed a linear response to SFD from 5.0 to 74.7μmol/L (R = 0.999) with detection and quantification limits of 0.92 and 3.10μmol/L, respectively. The developed SWV method showed better results for detection limit and linear range than the chronoamperometry method. It has been successfully applied to determine SFD concentration in pharmaceutical formulation, human urine and serum samples with recovery close to 100%.
其他文献
会议主题:糖尿病足病相关指南与诊疗规范化  由中华医学会、中华医学会糖尿病学分会主办,中华医学会糖尿病学分会糖尿病足与周围血管病学组承办的“中华医学会糖尿病学分会糖
应用中药糖复康胶囊治疗Ⅱ型糖尿病早期肾病 61例,总结如下。 rn1 一般资料 rn61例早期糖尿病肾病患者系 1997年 7月至 2000年 4月我院糖尿病专科门诊的Ⅱ型糖尿病患者。男 31
It is a well-known fact that sirolimus (SRL) undergoes degradation process via hydrolysis in aqueous media, leading to incorrect assessment of drug amount and t
从1968年问世至今,ERCP技术经历了从无到有,从诊断到治疗,从胆系到胰腺,从技术应用到并发症预防,从质控到培训的发展历程.一路风雨兼程,不断开拓创新,为人类发展做出了卓越贡
期刊
@@
目的 对利拉鲁肽应用于2型糖尿病合并动脉粥样硬化患者治疗中对其血糖、血脂、血压以及颈动脉斑块的影响进行观察与分析.方法 选取2型糖尿病合并动脉粥样硬化患者70例,将其随
目的:实验观察炎琥宁治疗小儿手足口病的临床效果.方法:将2017年8月至2018年8月我院收治的手足口病患儿120例参照计算机表法分组原则,分成观察组、对照组两组,对照组患儿使用
AIM: To investigate the anti-neoplastic effects of MK615,an extract from the Japanese apricot (Prunus mume),against colon cancer cells.METHODS: Three colon canc
目的评价西妥昔单抗联合化疗药与单用化疗药治疗晚期结直肠癌(ACRC)或转移性结直肠癌(mCRC)致严重不良反应(≥3级)的发生情况。方法检索MEDLINE、PubMed、Embase、Cochrane Library、中国知网、万方和维普数据库(建库至2014年9月),收集西妥昔单抗联合化疗药(试验组)和单用化疗药(对照组)治疗ACRC或mCRC的随机对照试验,采用RevMan 5.3软件对符合纳
期刊